抗甲状腺功能亢进症药物引起的以肺肾综合征为表现的ANCA相关性血管炎的临诊应对  

Approach to the patient with pulmonary-renal syndrome caused by antithyroid drug-induced ANCA-associated vasculitis

作　　者：谢君辉[1] 贺冶冰[1] 陈复琼[1] 何晓峰[2] 姚颖[2] 

机构地区：[1]华中科技大学同济医学院附属同济医院内分泌科,武汉430030 [2]华中科技大学同济医学院附属同济医院肾内科,武汉430030

出　　处：《中华内分泌代谢杂志》2014年第2期171-173,共3页Chinese Journal of Endocrinology and Metabolism

摘　　要：药物引起的ANCA相关性血管炎（antineutrophil aytoplasmic antibody—associated vasculitis，AAV）是一组具有潜在危及生命的自身免疫性疾病，抗甲亢药物是其中常见的病因之一。临床上常见累及皮肤，肾脏和（或）肺部。早期诊断和治疗至关重要，及时停用抗甲亢药物，或使用糖皮质类同醇和（或）免疫抑制剂等能延缓或阻止病情进展。Antineutrophil cy[oplasmie antibody-associated vasculitis （ AAV ） refers to the groups of potentially life-threatening autoimmune disease. Antithyroid drug is one of the causes. Usually the involved organs are skin, kidney, and（or） lung. Early diagnosis and treatment of AAV is essential. Timely cessation of antithyroid drugs is the first step. If necessary, glucocorticoids and （or） immunosuppressive agents should be used to delay the progression of the disease.

关 键 词：抗甲状腺功能亢进症药物 ANCA相关性血管炎 肺一肾综合征 

分 类 号：R581.1[医药卫生—内分泌]